[Polish] Delivery of medicinal products - Adalimumab (part no. 1)

This tender, originating from Poland and sourced via TED, concerns the supply of medicinal products, specifically focusing on Adalimumab, as part of Lot 1. Adalimumab is a biologic medication used to treat various autoimmune diseases. This procurement is for the acquisition of this specific pharmaceutical product. Typical requirements for tenders involving the supply of medicines include strict adherence to pharmaceutical quality standards, regulatory compliance with Polish and EU pharmaceutical legislation, and the ability to ensure product integrity throughout the supply chain. Bidders, usually pharmaceutical wholesalers or manufacturers, must demonstrate the legal authorization to distribute medicines in Poland. Requirements often include proof of origin, batch traceability, appropriate storage and transportation conditions (e.g., cold chain maintenance if necessary), and timely delivery to designated healthcare facilities or distribution points. The contracting authority, likely a public healthcare provider or procurement agency, will evaluate submissions based on the quality and authenticity of the product offered, compliance with pharmacopeial standards, competitive pricing, and the reliability of the supply chain. Detailed specifications regarding the dosage forms, packaging, and quantities required will be provided in the tender documentation.